Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis-Reference-Cited by-同舟云学术

Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis

Published:2021-05 Issue: Volume: Page:
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Anand Abhinav,Nambirajan Aruna,Kumar Vikas,Agarwal Samagra^ORCID,Sharma Sanchit,Mohta Srikant,Gopi Srikanth,Kaushal Kanav^ORCID,Gunjan Deepak^ORCID,Singh Namrata^ORCID,Madhusudhan Kumble S.^ORCID,Chauhan Shyam S.,Sharma Mehar C.,Bansal Virinder K.,Saraya Anoop

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older People;Cruz-Jentoft;Age Ageing,2010

2. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation;Krell;Liver Transpl,2013

3. Muscle wasting is associated with mortality in patients with cirrhosis;Montano-Loza;Clin Gastroenterol Hepatol,2012

4. Muscle mass predicts outcomes following liver transplantation;DiMartini;Liver Transpl,2013

5. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation;Hamaguchi;Liver Transpl,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric renal function assessment in cirrhotic patients shows high prevalence of medically actionable changes in multiple modules;Hepatology Research;2024-04-25

2. Correlation between sarcopenia and cirrhosis: a meta-analysis;Frontiers in Nutrition;2024-01-10

3. Cellular and molecular mechanisms of ammonia-induced neurotoxicity: a neurotherapeutic prospect;Natural Molecules in Neuroprotection and Neurotoxicity;2024

4. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota;World Journal of Gastroenterology;2023-07-21

5. Myostatin: a potential therapeutic target for metabolic syndrome;Frontiers in Endocrinology;2023-05-23